A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existing in vitro screening systems. The purpose of in vitro testing is to aid in the selection of efficacious compounds from a range of candidates with variable levels of the desired properties. In vitro cell-culture tumor models are the most widely used screening systems, however, they lack the complexity of the natural microenvironment of the host organism. Clearly, an effective screening system should possess qualities and organization similar to those of a natural tumor microenvironment. In an attempt to better simulate a tumor and its microenvironment sophisticated models have been developed, such as the three-dimensional cultures. In additio...
International audienceWorldwide, tumors are one of the most common causes of death. Every year 3.7 m...
Cancer is one of the major life threatening diseases worldwide. The available anticancer drugs have ...
Advances in the development of pharmacological treatment in oral cancer require tumor models capable...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
© Copyright © 2020 Kitaeva, Rutland, Rizvanov and Solovyeva. The development of new high-tech system...
Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a ratio...
Three-dimensional (3D) cultures are becoming increasingly popular due to their ability to mimic tiss...
Over the past few years, establishment and adaptation of cell-based assays for drug development and ...
The study of the development of anti-cancer drugs and preclinical efficacy tests has until today enc...
Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomim...
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor pr...
Cell culture is highly desirable, as it provides systems for ready, direct access and evaluation of ...
BACKGROUND:Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiologi...
Background: Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiolog...
International audienceWorldwide, tumors are one of the most common causes of death. Every year 3.7 m...
Cancer is one of the major life threatening diseases worldwide. The available anticancer drugs have ...
Advances in the development of pharmacological treatment in oral cancer require tumor models capable...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
© Copyright © 2020 Kitaeva, Rutland, Rizvanov and Solovyeva. The development of new high-tech system...
Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a ratio...
Three-dimensional (3D) cultures are becoming increasingly popular due to their ability to mimic tiss...
Over the past few years, establishment and adaptation of cell-based assays for drug development and ...
The study of the development of anti-cancer drugs and preclinical efficacy tests has until today enc...
Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomim...
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor pr...
Cell culture is highly desirable, as it provides systems for ready, direct access and evaluation of ...
BACKGROUND:Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiologi...
Background: Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiolog...
International audienceWorldwide, tumors are one of the most common causes of death. Every year 3.7 m...
Cancer is one of the major life threatening diseases worldwide. The available anticancer drugs have ...
Advances in the development of pharmacological treatment in oral cancer require tumor models capable...